Chronic cough, persisting for over eight weeks, is a common yet challenging condition encountered in clinical practice. Despite its prevalence, the multifactorial nature often leads to diagnostic uncertainty and therapeutic complexity.
Initial diagnostic efforts should focus on identifying common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) due to rhinosinus conditions. If these are excluded, consider less common etiologies, including non-asthmatic eosinophilic bronchitis, chronic bronchitis, and bronchiectasis. A systematic approach, including a detailed history, physical examination, and targeted investigations, remains paramount.
High-resolution computed tomography (HRCT) can reveal bronchiectasis, interstitial lung disease, or malignancies, while Pulmonary Function Tests (PFTs) can uncover obstructive or restrictive abnormalities. However, their routine use is not recommended, and they should be reserved for cases with unexplained symptoms or abnormal initial investigations.
Treatment should be etiology-specific and may involve lifestyle modifications, pharmacological interventions, or rarely, surgery. Empirical therapy for GERD, UACS, or asthma can be considered if the diagnosis is uncertain. Refractory cases may benefit from referral to a cough specialist or a multidisciplinary team.
Emerging research focuses on understanding the pathophysiology of chronic cough, including the role of neuronal hypersensitivity and novel therapeutic targets. However, the translation of these findings into clinical practice requires further studies.
Chronic cough poses diagnostic and therapeutic challenges in medical practice. A comprehensive and systematic approach, coupled with an understanding of common and uncommon causes, is essential for effective management. Future research promises to enhance our understanding and treatment of this complex condition.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation